Dan Bowles

Apr 23, 2024 | drugdiscoveryonline.com | Steve Fawell |Jean-Sebastien Steffen |Dan Bowles

Progress with PROTACs and molecular glues hasn’t come without challenges, particularly in identifying the right chemistry starting point for drug development — a process known as hit discovery. This article looks at the role of CRISPR, screening assays, and more.

Oct 17, 2023 | drugdiscoveryonline.com | Sabyasachi Ghosh |Dan Bowles |Mike Johnson |Brian Swierenga

The U.S. is at the forefront of the AI-based research trend surge to elevate the understanding of human physiology, testing potential therapies, and identifying disease mechanisms. Let's examine the five most promising innovative advancements in animal models, as well as key considerations for those working in the field.